
Join to View Full Profile
Sierra Infectious Disease5458 Reno Corporate DrReno, NV 89511
Dr. Adrianza is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Andres Adrianza is an infectious disease specialist based in Reno, NV. He completed his fellowship in infectious disease at Texas A&M College of Medicine-Scott and White Medical Center in 2024, after finishing his internal medicine residency at the University of Texas RGV in 2022. He graduated from the University of Zulia in 2013. Dr. Adrianza is currently a physician at Sierra Infectious Diseases. His previous role was as a research assistant at UT MD Anderson Cancer Center. He has authored several publications, including works on microbiota, bacteremia, infliximab, thoracentesis, and thoracolithiasis, some of which have been cited in other scholarly articles.
Education & Training
- Baylor Scott & White Medical Center - Baylor College of Medicine (Temple)Fellowship, Infectious Disease, 2022 - 2024
- University of Texas RGV (VBMC)Residency, Internal Medicine, 2019 - 2022
- University of ZuliaClass of 2013
Certifications & Licensure
- NV State Medical License 2024 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Understanding the significance of microbiota recovered from health care surfaces.Chetan Jinadatha, Thanuri Navarathna, Juan Negron-Diaz, Gautam Ghamande, Brandon A Corona
American Journal of Infection Control. 2024-02-01 - 2 citationsbacteremia associated with diarrhea.Andres Adrianza, Niloufar Pourfarrokh, Hosoon Choi, Munok Hwang, Janell Lukey
Idcases. 2023-01-01 - 5 citationsRole of Infliximab in Immune Checkpoint Inhibitor-Induced Pneumonitis.Kathryn A Lai, Ajay Sheshadri, Andres M Adrianza, Mikel Etchegaray, Diwakar D Balachandran
Journal of Immunotherapy and Precision Oncology. 2020-11-01
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: